Pharma Eases onto the Grid, but Desktop Deals Highlight Remaining Obstacles | GenomeWeb

Pharma isn’t known for its “power to the people” philosophy, but when it comes to computational power, pharmaceutical companies are embracing the idea. Pharma is gradually adopting various forms of grid computing, which harnesses the unused processing cycles of all computers in a network. Recent deals for this technology have given grid software vendors a dose of optimism about the market potential for their tools, as well as a reality check about the capabilities and limitations of the technology for life science informatics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.